Celgene Pulmonary Fibrosis Foundation, Celgene Form Biomarker Consortium The consortium aims to develop assays that can detect biomarkers of pulmonary fibrosis that can be used as early indicators of a treatment's activity. Evotec, Celgene Partner on Targeted Protein Degradation for Drug Discovery The collaboration will involve Evotec's Panomics platform, which integrates the analysis of genomic, transcriptomic, and proteomic data. NIH Launches Parkinson's Disease Research Partnership The partnership includes biopharmaceutical, life science, and non-profit organizations, as well as several US government agencies. ArcherDx to Develop CDx for Celgene's Lymphoma Drug Candidate The companion diagnostic will leverage ArcherDx's Anchored Multiplex PCR technology, Illumina's MiSdqDx sequencer, and Archer Analysis bioinformatics software. NIH Partners With Biopharmaceutical Firms on $215M Cancer Immunotherapy Research Initiative The alliance's first aim is the identification, development, and validation of biomarkers of cancer and treatment response. Aug 1, 2017 Abbott Receives FDA Approval for IDH2 Mutation CDx Alongside AML Drug May 31, 2017 ImiDomics, Celgene Partner on Immune-Mediated Inflammatory Disease Research Dec 7, 2016 GNS Healthcare Expects Increased Biopharma Interest in Causal Machine-Learning Tech Premium Dec 5, 2016 Celgene, Dana-Farber, University of Arkansas Form Myeloma Genome Project Nov 30, 2016 Penn Cancer Center Taps Tempus to Identify Immunotherapy Response Indicators Oct 24, 2016 Precision Medicine Master Trial Aims to Tailor Therapy for Acute Myeloid Leukemia Patients Premium Oct 12, 2016 Abbott Inks CDx Development, Commercialization Deals With Celgene, Agios May 24, 2016 Novartis, Foundation Medicine, Celgene Invest in Healthcare Informatics Firm COTA Jan 28, 2016 Human Longevity Acquires Stem Cell Banking Business Unit from Celgene Oct 23, 2015 MED-C Launches First Registry in NSCLC With Funding Agreements from Pharma, Sequencing Companies Premium Mar 2, 2015 UAMS Myeloma Institute to Create MDx Center, Endowed Chair with $10M Celgene Gift Aug 11, 2014 Human Longevity, Celgene Cellular Therapeutics Ink Deal for Placental Cell Population Jun 4, 2014 NanoString to Develop Companion Dx for Celgene Lymphoma Drug Study Dec 4, 2013 NYC, Corporate Partners Launch $100M Life Sciences Investment Fund Sep 25, 2013 Agios Begins Studying AG-221 for IDH2-Mutated Hematologic Cancer in Phase I Dosing Trial Premium Oct 17, 2012 Acceleron Exploring New Biomarker Leads to Personalize Treatment for Breast, Head and Neck Cancers Premium Aug 15, 2012 Epic Sciences Developing CTC-based CDx with Drug Firms May 22, 2012 Smithsonian Museum to Launch Genomics Exhibit Supported by Life Technologies Foundation May 16, 2012 With Celgene Partnership Epizyme Hopes to Accelerate Personalized Epigenetic Drug Development Premium Nov 10, 2011 Startup Quanticel, Fresh off $45M Celgene Deal, Using Fluidigm Tech in Single-Cell Genomic Analyses Premium Load More Breaking News Roche Receives EUA for PCR-Based, Point-of-Care SARS-CoV-2 Test Decode Study Identifies Proteomic Predictors of All-Cause Mortality In Brief This Week: Natera, Bruker, Bayer, and More New Products Posted to GenomeWeb: Labcorp, Omniseq, Dovetail Genomics, DNA Script, More People in the News: New Appointments at Sema4, Strata Oncology, Bionano Genomics, More Co-Diagnostics Gets CE Mark for Saliva-Based Molecular SARS-CoV-2 Test The Scan Billions for Antivirals The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports. NFT of the Web Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports. 23andMe on the Nasdaq 23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported. Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.